Apella, a health technology company, today announced it raised $80 million in Series B equity and venture debt. The round was led by HighlandX, with returning investors Vensana Capital, Casdin Capital, PFM Health Sciences, Upside Partnership, and Operator Partners, and includes new investors K2 HealthVentures, OpAmp Capital, and Houston Methodist.
“Ambient AI is transforming healthcare,” said David Schummers, Co-Founder and CEO of Apella. “We have applied this technology to the most critical part of the health system: the operating room. Our customers have expanded beyond the pilot phase, bringing Apella’s product suite to enterprise scale. In doing so, health systems are unlocking additional capacity to serve more patients, faster.”
Read More – Rain Raises $250M in Series C Funding
Apella provides hospitals with a comprehensive platform for OR management. Using computer vision and machine learning to automatically collect and identify up to 14 surgical case events and autonomously write novel data back to the EHR, Apella ensures healthcare professionals can focus on serving more patients and still go home on time. Apella’s partners include leading systems like Houston Methodist, Tampa General Hospital, and the Medical University of South Carolina (MUSC). On average, hospitals that use Apella have experienced a 5% increase in surgical volume.
“The depth at which hospital staff are adopting Apella and incorporating it in their everyday workflows is exciting,” said Corey Mulloy of HighlandX, who has joined Apella’s Board of Directors. “Health technology — even when it delivers hard ROI — rarely becomes such an integral part of providers’ day-to-day or a problem-solver for health systems.”
Read More – Rakuten Medical Raises $100M in Series F Funding
